BMO Capital raised the firm’s price target on Celestica (CLS) to $370 from $300 and keeps an Outperform rating on the shares after its Q3 earnings beat. The company is seeing stronger-than-expected demand from its three large hyperscaler customers heading into FY26, with a growing pipeline of additional opportunities driven by a combination of strong end-market demand, its competitive differentiation and favorable technical trends that play to its strengths, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLS:
- Celestica price target raised to $440 from $340 at Goldman Sachs
- Celestica price target raised to $388 from $305 at JPMorgan
- Celestica price target raised to $357 from $220 at Barclays
- Celestica’s Manufacturing Shifts: Navigating Risks and Financial Impacts
- Celestica Reports Strong Q3 2025 Results and Raises Outlook